Gemtuzumab ozogamicin: One size does not fit all - The case for personalized therapy

Farhad Ravandi

doi:10.1200/JCO.2010.32.2693

Gemtuzumab ozogamicin: One size does not fit all - The case for personalized therapy

Farhad Ravandi

Leukemia

Research output: Contribution to journal › Editorial › peer-review

28 Scopus citations

Original language	English (US)
Pages (from-to)	349-351
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	29
Issue number	4
DOIs	https://doi.org/10.1200/JCO.2010.32.2693
State	Published - Feb 1 2011

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2010.32.2693

Cite this

@article{921a2d29fc2a45e0bf1d42d243b59c08,

title = "Gemtuzumab ozogamicin: One size does not fit all - The case for personalized therapy",

author = "Farhad Ravandi",

year = "2011",

month = feb,

day = "1",

doi = "10.1200/JCO.2010.32.2693",

language = "English (US)",

volume = "29",

pages = "349--351",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "4",

}

TY - JOUR

T1 - Gemtuzumab ozogamicin

T2 - One size does not fit all - The case for personalized therapy

AU - Ravandi, Farhad

PY - 2011/2/1

Y1 - 2011/2/1

UR - http://www.scopus.com/inward/record.url?scp=79952082752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952082752&partnerID=8YFLogxK

U2 - 10.1200/JCO.2010.32.2693

DO - 10.1200/JCO.2010.32.2693

M3 - Editorial

C2 - 21172885

AN - SCOPUS:79952082752

SN - 0732-183X

VL - 29

SP - 349

EP - 351

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 4

ER -

Gemtuzumab ozogamicin: One size does not fit all - The case for personalized therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this